Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
Currently, acetylsalicylic acid (ASA) is one of the main medications in cardiovascular prevention. Preventive ASA therapy has some specific pharmacokinetic and pharmacodynamic features, also depending on the medication form. The maximal ASA effectiveness is observed for low doses of 75-150 mg/d. The...
Main Authors: | V. V. Rafalsky, A. V. Krikova, A. N. Baglikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1651 |
Similar Items
-
Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01) -
LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS
by: V. V. Rafalsky, et al.
Published: (2017-08-01) -
Клиническая фармакология ацетилсалициловой кислоты и особенности лекарственных форм – ключ к эффективному и безопасному применению для профилактики тромбозов
Published: (2016-12-01) -
Ацетилсалициловая кислота в первичной профилактике сердечно-сосудистых заболеваний: уточненные данные
Published: (2018-06-01) -
ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE?
by: S. A. Boldueva, et al.
Published: (2015-12-01)